SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form CORRESP - Correspondence:
SEC Accession No. 0001193125-19-157094
Filing Date
2019-05-24
Accepted
2019-05-24 16:43:55
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 16283
2 GRAPHIC g673777g0523052622291.jpg GRAPHIC 2406
  Complete submission text file 0001193125-19-157094.txt   20661
Mailing Address 430 EAST 29TH STREET, SUITE 940 NEW YORK NY 10016
Business Address 430 EAST 29TH STREET, SUITE 940 NEW YORK NY 10016 917-336-9310
Prevail Therapeutics Inc. (Filer) CIK: 0001714798 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2836 Biological Products, (No Diagnostic Substances)